Cell & Gene Therapy
The Phacilitate Cell & Gene Therapy Forum celebrated its 10th Birthday in Washington, DC on January, 27th-29th. We marked the occasion by delivering the biggest and best event in the series' history.
Building on a record attendance in 2013 (more than 350 of the most senior decision-makers in the cell therapy, gene therapy and tissue engineered product sectors) we welcomed our largest ever speaker panel to the event – more than 100 of the most influential payers, regulators, investors, big pharma cheque-writers and, of course, the leading lights of the global cell & gene therapy industry itself.
And brand new for 2014, we featured a full 2-day conference stream dedicated to Stem Cells as Discovery & Research Tools, driving even more attendees from major pharma and biotech companies to the event.
As in previous years, the event was collocated with the Washington Vaccine Forum. However, this conference transformed into the Phacilitate Vaccine & Immunotherapy Forum in 2014, meaning greater synergy with the Cell & Gene Therapy Forum through dedicated coverage of cell-based immunotherapy and other therapeutic vaccine technologies.
We welcomed well over 500 attendees in total to our Washington 2014 meeting, with all networking shared and every conference session available to each attendee. PLUS delegates received access to an online pre-event Partnering Service, allowing them to contact individuals and organise meetings before they arrived onsite.